Skip to content
Quantum Zeitgeist
  • Quantum Computing
    • Quantum Computing News
    • Quantum Research News
    • Quantum Computing Business News
    • Quantum Algorithms
    • Quantum Physics
    • Quantum Hardware
    • Quantum Applications
    • Quantum Security
    • Quantum Sensors
    • Quantum Machine Learning
    • Quantum Funding Landscape
    • Quantum Internet
    • Quantum Features
    • Quantum Programming
    • Quantum Cryptography
    • Quantum Companies
    • Quantum Cloud
  • Technology News
    • Physics
    • Artificial Intelligence
    • Metaverse
    • Machine Learning
    • Robotics
    • Technology Features
  • Quantum Navigator

Tag: drug design

  • Equi-ensemble Description Systematically Outperforms Weighted-ensemble Variational Quantum Eigensolver for Excited-State Calculations
    Quantum Features, Quantum Research News

    Equi-ensemble VQE Boosts Excited-State Calculations

    by Muhammad Rohail T.September 25, 2025
  • Kvantify Leverages Gefion Supercomputer to Revolutionize Quantum Computing Simulation for Drug Discovery
    Drug Discovery

    Kvantify & Gefion Boost Quantum Drug Simulation

    by Dr. DonovanMay 14, 2025
  • Qubit Pharmaceuticals. How AI-Powered Quantum Chemistry is Transforming Molecular Simulations
    Drug Discovery

    Quantum Chemistry: AI Speeds Drug Simulations

    by Dr. DonovanMay 8, 2025
  • LLNL Scientists Advance Understanding of Protein-Membrane Interactions with Dynamic Density Functional Theory Model
    Drug Discovery

    DDFT Models Protein-Membrane Interactions at LLNL

    by Dr. DonovanMarch 27, 2025
  • Breakthrough in Analog Quantum Computing Accelerates Drug Discovery Process
    Drug Discovery

    Analog Quantum Computing Speeds Drug Discovery

    by Dr. DonovanOctober 8, 2024
  • Quantum Computing Hopes to Revolutionize Drug Discovery Process
    Drug Discovery

    Quantum Computing Speeds Drug Discovery

    by Dr. DonovanSeptember 30, 2024
  • Quantum Computing for Drug Design A New Approach to Healthcare
    Quantum Applications

    Quantum Computing Aids Drug Design

    by Dr. DonovanSeptember 7, 2024
  • Quantum Computing Revolutionising Pharma: Speeding Drug Design and Accelerating Clinical Studies
    Drug Discovery, Quantum Research News

    Quantum Computing Speeds Drug Design & Studies

    by Dr. DonovanJune 3, 2024
  • AlphaFold 3: Google DeepMind's AI Revolutionises Drug Discovery with Unprecedented Molecular Predictions
    Quantum Research News

    AlphaFold 3 Predicts Molecular Interactions

    by Dr. DonovanMay 10, 2024
  • Researchers Develop Quantum Algorithm for Advanced Chemistry Calculations, Aiding Drug Design
    Drug Discovery

    Quantum Algorithm Speeds Drug Design Chemistry

    by Dr. DonovanMarch 14, 2024
  • Researchers Develop APNet: A Quantum Leap in Predicting Protein-Ligand Interactions
    Quantum Research News

    Quantum QC Predicts Protein-Ligand Interactions

    by Dr. DonovanFebruary 18, 2024
  • Quantum-Inspired Machine Learning Boosts Efficiency in Drug Development, Outperforms Traditional Methods
    Quantum Applications

    Quantum ML Speeds Drug Development

    by Dr. DonovanJanuary 29, 2024
  • Edinburgh UK to Host Exascale System, Revolutionising AI, Medicine, and Clean Energy Research
    Technology News

    Exascale System to Boost AI, Medicine, Energy Research

    by sigmoidOctober 11, 2023
Quantum Computing News
Bluesky Logo

Quantum Computing

  • Quantum Applications
  • Quantum Books
  • Quantum Computing Courses
  • Quantum Machine Learning
  • Quantum Programming

Quantum Computing

  • Quantum Cloud
  • Quantum Landscape
  • Quantum Cryptography
  • Quantum Finance
  • Quantum Hardware
  • Quantum Internet
  • Quantum Investment

Technology

  • Artificial Intelligence
  • Analog Computing
  • Deep Tech
  • Emerging Technology
  • High Performance Computing
  • Machine Learning
  • Space
  • Science
  • Robotics

About Us

  • About Us
  • Write for Us
  • Terms and Conditions
  • Privacy Policy
  • Contact Us

Disclaimer: All material, including information from or attributed to Quantum Zeitgeist or individual authors of content on this website, has been obtained from sources believed to be accurate as of the date of publication. However, Quantum Zeitgeist makes no warranty of the accuracy or completeness of the information and Quantum Zeitgeist does not assume any responsibility for its accuracy, efficacy, or use. Any information on the website obtained by Quantum Zeitgeist from third parties has not been reviewed for accuracy.

Copyright 2019 to 2026 The Quantum Zeitgeist website is owned and operated by Hadamard LLC, a Wyoming limited liability company.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}